SCHEMBL30726366

SCHEMBL30726366

O=[N+]([O-])c1cnc(Cl)cc1NC1CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
MAPT P10636 5/20 0.47
MAPK1 P28482 2/20 0.47
HCAR3 P49019 3/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
GAA P10253 2/20 0.45
GLA P06280 1/20 0.45
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
HTT P42858 1/20 0.44
CDK2 P24941 1/20 0.43
DCTPP1 Q9H773 1/20 0.41
WNK1 Q9H4A3 2/20 0.40
GSK3A P49840 1/20 0.39
GSK3B P49841 1/20 0.39
POLB P06746 1/20 0.39
ALDH1A1 P00352 3/20 0.39
BCL6 P41182 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15174387 1.00 MEN1 (0.49) MEN1KMT2AMAPTMAPK1HCAR3
SCHEMBL15740508 0.94 MEN1 (0.57) MEN1KMT2AMAPTMAPK1HCAR3
SCHEMBL15740481 0.94 MEN1 (0.53) MEN1KMT2AMAPTMAPK1HCAR3
SCHEMBL10270108 0.93 MEN1 (0.44) MEN1KMT2AMAPTMAPK1HCAR3
SCHEMBL15740701 0.93 KMT2A (0.59) MEN1KMT2AMAPTMAPK1HCAR3
SCHEMBL26774910 0.92 BCL6 (0.47) MEN1KMT2AMAPTMAPK1HCAR3
SCHEMBL572975 0.90 HCAR3 (0.48) MEN1KMT2AMAPTMAPK1HCAR3
SCHEMBL572153 0.90 HCAR3 (0.48) MEN1KMT2AMAPTMAPK1HCAR3
SCHEMBL572154 0.90 HCAR3 (0.48) MEN1KMT2AMAPTMAPK1HCAR3
SCHEMBL30578514 0.90 MEN1 (0.41) MEN1KMT2AMAPTMAPK1HCAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4558495-A1 HETEROARYL COMPOUNDS AS LIGAND DIRECTED DEGRADERS OF IRAK4 Bristol-Myers Squibb Company (US) 2025-05-28 EP disclosed
WO-2024020084-A1 HETEROARYL COMPOUNDS AS LIGAND DIRECTED DEGRADERS OF IRAK4 BRISTOL-MYERS SQUIBB COMPANY (US) 2024-01-25 WO disclosed